CED Clinical Relevance #64Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch | CED Clinic CbdPediatricNeurodevelopmentalTransdermalOpen-Label JournalJournal of neurodevelopmental disordersStudy TypeOpen-Label TrialPopulationHuman participants Why This Matters22q11.2 deletion syndrome affects 1 in...
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Clinical Takeaway Transdermal cannabidiol gel (ZYN002) has been studied in children and adolescents with Fragile X syndrome through an open-label extension trial focused on long-term safety and tolerability. Early interim data suggest...